International Advisory Board
■ Dr. Karen AntmanDeputy Director for Translational and Clinical Science, National Cancer Institute,Maryland, USA
■ Dr. Jean-Pierre ArmandProfessor, Department of Medicine, Institut Gustave Roussy,France.
■ Dr. Otis BrawleyChief Medical Officer & EVP Research and Cancer Control Science, American Cancer Society Georgia, USA
■ Dr. Bruce ChabnerClinical Director, Massachusetts General Hospital Cancer Center, Harvard Medical School.Massachusetts, USA
■ Dr. William DaltonCEO and Director, H. Lee Moffitt Cancer Center and Research Institute Florida,USA
■ Dr. Philip DiSaiaProfessor and Director, Division of Gynecologic Oncology, University of California Medical Center, California, USA.
■ Dr. Michael FriedmanPresident and CEO, City of Hope,California, USA
■ Dr. Anne KolkerExecutive Director, The National Ovarian Cancer Coalition,USA
■ Dr. Lawrence S. LessinSenior Executive Physician, Washington Cancer Institute, Washington Hospital Center,Washington, USA
■ Dr. James LynchVice President of Hospital and Medical Science Administration, Fox Chase Cancer Center,Philadelphia, USA
■ Dr. Herbert PinedoAdvisor, Free University Cancer Center,Amsterdam, The Netherlands
■ Dr. Raul RibeiroDirector, International Outreach Program, St. Jude Children's Research Hospital,Tennessee, USA
■ Dr. Ulrik RingborgProfessor, Department of Oncology, Karolinska University Hospital,Stockholm, Sweden
■ Dr. Steven RosenDirector, Robert H. Lurie Comprehensive Cancer Center, Northwestern University,Illinois, USA
■ Dr. Youcef RustumSr. Vice President for Science Administration, Roswell Park Cancer Institute,New York, USA
■ Dr. John SeffrinCEO, American Cancer Society,USA
■ Mr. Raj ShahChairman and CEO, Capital Technology Information Services,Maryland, USA
■ Dr. Daniel Von HoffSenior Investigator, Translational Genomics Research Institute (TGen),Arizona, USA
■ Dr. Robert WittesPhysician-in-Chief, Memorial Sloan Kettering Cancer Center,New York, USA.
